Shenzhen Chipscreen Biosciences Co (SHSE:688321) Market Cap: ¥12,504 Mil (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688321 Shenzhen Chipscreen Biosciences Co Ltd SHSE:688321
74 GF Score
Price ¥28.23
GF Value ¥38.00
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Shenzhen Chipscreen Biosciences Co Market Cap?

Shenzhen Chipscreen Biosciences Co SHSE:688321 +3.79% 74 Market Cap is ¥12,504 Mil as of Jul. 14, 2026. GuruFocus rates SHSE:688321 with a GF Score™ of 74/100 and a GF Value™ of ¥38.00 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Shenzhen Chipscreen Biosciences Co ranks better than 83.69% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shenzhen Chipscreen Biosciences Co's share price for the quarter that ended in Mar. 2026 was ¥28.57. Shenzhen Chipscreen Biosciences Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 443 Mil. Therefore, Shenzhen Chipscreen Biosciences Co's market cap for the quarter that ended in Mar. 2026 was ¥12,655 Mil.

Shenzhen Chipscreen Biosciences Co's quarterly market cap declined from Sep. 2025 (¥13,082 Mil) to Dec. 2025 (¥11,916 Mil) but then increased from Dec. 2025 (¥11,916 Mil) to Mar. 2026 (¥12,655 Mil).

Shenzhen Chipscreen Biosciences Co's annual market cap declined from Dec. 2023 (¥9,028 Mil) to Dec. 2024 (¥7,577 Mil) but then increased from Dec. 2024 (¥7,577 Mil) to Dec. 2025 (¥11,916 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shenzhen Chipscreen Biosciences Co's Enterprise Value for Today is ¥12,077 Mil.


Shenzhen Chipscreen Biosciences Co  (SHSE:688321) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Shenzhen Chipscreen Biosciences Co Market Cap Related Terms


Shenzhen Chipscreen Biosciences Co Market Cap Historical Data

* Premium members only.

The historical data trend for Shenzhen Chipscreen Biosciences Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Chipscreen Biosciences Co Market Cap Chart

Shenzhen Chipscreen Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,379.34 9,027.65 9,027.75 7,576.85 11,916.15

Shenzhen Chipscreen Biosciences Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,397.42 9,697.39 13,082.48 11,916.15 12,654.82

SHSE:688321 vs ZTS, UTHR: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Chipscreen Biosciences Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Chipscreen Biosciences Co Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Chipscreen Biosciences Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Shenzhen Chipscreen Biosciences Co's Market Cap falls into.


SHSE:688321
74GF Score
Shenzhen Chipscreen Biosciences Co Ltd SHSE:688321
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Chipscreen Biosciences Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shenzhen Chipscreen Biosciences Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=¥29.22*407.808
=¥11,916

Shenzhen Chipscreen Biosciences Co's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=¥28.57*442.941
=¥12,655

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of ¥12,504 Mil mean?
Shenzhen Chipscreen Biosciences Co (SHSE:688321) has a Market Cap of ¥12,504 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. According to the industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #167 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 16.3%.
Is Shenzhen Chipscreen Biosciences Co's Market Cap too high?
Shenzhen Chipscreen Biosciences Co's current Market Cap is ¥12,504 Mil. Based on the distribution chart, Shenzhen Chipscreen Biosciences Co ranks #167 out of 1024 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shenzhen Chipscreen Biosciences Co has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Chipscreen Biosciences Co's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #167 out of 1024 companies for Market Cap. This places Shenzhen Chipscreen Biosciences Co in the top 16% of its industry — outperforming the majority of peers. The industry median Market Cap is 211.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 211.96, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 211.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Chipscreen Biosciences Co's current Market Cap is ¥12,504 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Chipscreen Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co (SHSE:688321) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥38.00, compared to a current price of ¥28.23 — trading 25.7% below its estimated fair value. The current Market Cap is ¥12,504 Mil. Shenzhen Chipscreen Biosciences Co's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Shenzhen Chipscreen Biosciences Co (SHSE:688321), the current Market Cap is ¥12,504 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen Chipscreen Biosciences Co (SHSE:688321) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co stock appears to be undervalued. The current stock price of ¥28.23 is trading 25.7% below its estimated GF Value™ of ¥38.00. GuruFocus considers Shenzhen Chipscreen Biosciences Co to be Modestly Undervalued.

Key valuation signals for SHSE:688321:

  • Market Cap: ¥12,504 Mil
  • GF Value™: ¥38.00 vs. price of ¥28.23 (25.7% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shenzhen Chipscreen Biosciences Co Business Description

Address No. 10, Gaoxin Zhongyi, Room 601-606, Building 2, Shenzhen Biological Incubation Base, Gaoxin Zhongyi, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Shenzhen Chipscreen Biosciences Co Ltd is engaged in the research and development of small molecule drugs.
74GF Score

Get the complete analysis for SHSE:688321

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.23
Price
¥38.00
GF Value